TAIWAN · TWSE / TPEx
MBI
和康生 · 1783 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$37.001 month +2.2% · 1 year -17.4%
Directors and supervisors hold38,055,49042.4% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold27,976,76231.2% of shares issued
Revenue, 2026-09+35.3%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 大江生醫股份有限公司 | Chairman · Director · Major shareholder (10%+) | 20,304,762 | 27,976,762 | 31.19% | — | — |
| 林詠翔 | Chairman (corporate representative) | — | 560,000 | 0.62% | — | 1,755,705 |
| 中加投資發展股份有限公司 | Director | 1,376,688 | 1,376,688 | 1.53% | — | — |
| 李啟睿 | Director (corporate representative) | — | 0 | — | — | — |
| 台塑生醫科技股份有限公司 | Director | 8,702,040 | 8,702,040 | 9.70% | — | — |
| 賴世明 | Director (corporate representative) | — | 0 | — | — | — |
| 陳敬亭 | Director (corporate representative) · President · Other | — | 146,402 | 0.16% | — | 2,310 |
| 李秋月 | Director (corporate representative) | — | 0 | — | — | — |
| 林欣榮 | Director (corporate representative) | — | 0 | — | — | — |
| 廖松淵 | Independent director | — | 0 | — | — | — |
| 曾仲銘 | Independent director | — | 0 | — | — | — |
| 陳適安 | Independent director | — | 0 | — | — | — |
| 賴柏宏 | Vice president | — | 85,997 | 0.10% | — | — |
| 吳瑞益 | Chief financial officer · Chief accountant | — | 0 | — | — | — |
| 黃振嘉 | Other | — | 0 | — | — | — |